Treatment of metastatic glucagonoma to the liver: case report and literature review
- PMID: 10425577
Treatment of metastatic glucagonoma to the liver: case report and literature review
Abstract
Glucagonoma, a rare neuroendocrine pancreatic tumour, is frequently malignant and often accompanied by hepatic metastases. Our aim was to consider the different treatments of metastatic glucagonoma to the liver and their results. A case of glucagonoma with metachronous, small, multiple and bilobar liver metastases is reported. Combined treatment with octreotide and hepatic arterial chemoembolization was applied with good results in terms of symptom relief, plasma glucagon levels and regression of hepatic metastases. Survival rates were also improved. Based on our experience, glucagonoma with metachronous, multiple, diffuse and bilobar hepatic metastases should be treated with octreotide plus hepatic arterial chemoembolization with improved outcome and prognosis.
Similar articles
-
[Diagnostic imaging of glucagonoma and transcatheter arterial embolization in hepatic metastases--report of a case].Rinsho Hoshasen. 1986 Mar;31(3):433-6. Rinsho Hoshasen. 1986. PMID: 3014183 Japanese. No abstract available.
-
Metastatic glucagonoma: treatment with liver transplantation.J Am Acad Dermatol. 2006 Feb;54(2):344-7. doi: 10.1016/j.jaad.2005.05.023. J Am Acad Dermatol. 2006. PMID: 16443073
-
Scintigraphic long-term follow-up of a patient with metastatic glucagonoma.Am J Gastroenterol. 2000 Jul;95(7):1818-20. doi: 10.1111/j.1572-0241.2000.02164.x. Am J Gastroenterol. 2000. PMID: 10925991
-
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.Digestion. 1989;42(2):116-20. doi: 10.1159/000199835. Digestion. 1989. PMID: 2548911 Review.
-
[Treatment of liver metastasis of endocrine tumors of the pancreas].Rev Gastroenterol Mex. 1997 Jan-Mar;62(1):50-6. Rev Gastroenterol Mex. 1997. PMID: 9190654 Review. Spanish.
Cited by
-
Somatostatin Analogs in Clinical Practice: a Review.Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
-
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Front Endocrinol (Lausanne). 2014 Feb 7;5:7. doi: 10.3389/fendo.2014.00007. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 24570674 Free PMC article. Review.
-
Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy.Front Endocrinol (Lausanne). 2021 May 19;12:679000. doi: 10.3389/fendo.2021.679000. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34093445 Free PMC article. Review.
-
Hepatic arterial embolization in patients with neuroendocrine tumors.J Exp Clin Cancer Res. 2014 May 19;33(1):43. doi: 10.1186/1756-9966-33-43. J Exp Clin Cancer Res. 2014. PMID: 24887262 Free PMC article. Review.
-
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.J Exp Clin Cancer Res. 2010 Mar 2;29(1):19. doi: 10.1186/1756-9966-29-19. J Exp Clin Cancer Res. 2010. PMID: 20196864 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical